Skip to main content
APUS logo

APUS · Apimeds Pharmaceuticals US, Inc.

$5.65 +5.00 (+764.84%) At close · Jul 24
Market Cap
$85.27M
Shares
15.09M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 6
Total Value: $802,820
Total Shares: 448,756

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 6 13F filers · Δ vs Dec 31, 2025
Top Holder
61.1%
Jun 2025 → Mar 2026 · range 61.1% – 89.8%
−8.2 pts
Top 5
99.1%
Jun 2025 → Mar 2026 · range 96.6% – 100.0%
−0.9 pts
Top 10
100.0%
Jun 2025 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
4,300
Jun 2025 → Mar 2026 · range 4,265 – 8,099
Highly concentrated−842

Quarterly Activity

vs Dec 31, 2025
New
3
Increased
3
Decreased
0
Sold Out
5
Unchanged
0
Holder count: -2
Institutional value: -97.3%
Shares held: -75.0%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
No qualifying movers this quarter.

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 6 of 6
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1894525 CUSIP 03771D102 Visit website